Cellebrite (CLBT) shares surged 5.08% in pre-market trading on Thursday following the release of its impressive second-quarter 2025 financial results, the appointment of a new CEO, and an optimistic future outlook. The digital intelligence solutions provider demonstrated robust growth across key financial metrics, surpassing analyst expectations in several areas.

For Q2 2025, Cellebrite reported revenue of $113.276 million, beating the consensus estimate of $112.2 million. The company's subscription revenue saw a significant 21% year-over-year increase to $103.0 million, while Annual Recurring Revenue (ARR) grew by 21% to $418.9 million. The adjusted EBITDA came in at $27.885 million, also exceeding analyst expectations, with an impressive margin of 24.6%.

Adding to the positive news, Cellebrite announced the appointment of Thomas E. Hogan as its permanent CEO, effective immediately. Hogan, who had been serving as interim CEO since January, expressed confidence in the company's growth trajectory and its ability to support customers in law enforcement, defense, and intelligence sectors. The combination of strong financial performance and new leadership appears to have bolstered investor confidence.

Looking ahead, Cellebrite provided an encouraging outlook for Q3 and full-year 2025. The company expects Q3 revenue between $121 million and $126 million, with adjusted EBITDA of $31 million to $34 million. For the full year, Cellebrite projects revenue ranging from $465 million to $475 million. The company also highlighted ongoing strategic initiatives, including progress on its FedRAMP authorization journey and the pending acquisition of Corellium, which is expected to enhance its digital investigation capabilities.